Hasil pencarian
11 obat untuk "CEFDITOREN PIVOXIL"
Kelas terapi:
Semua
A · Saluran Cerna & Metabolisme
B · Darah & Pembentuk Darah
C · Kardiovaskular
D · Dermatologika
G · Genitourinari & Hormon Seks
H · Hormon Sistemik
J · Antiinfeksi
L · Antineoplastik & Imunomodulator
M · Muskuloskeletal
N · Sistem Saraf
P · Antiparasit
R · Sistem Pernapasan
S · Organ Sensorik
V · Varia
| Nama Obat | No. Registrasi | Sediaan | Kandungan | Status |
|---|---|---|---|---|
|
CEFDITOREN PIVOXIL
PRATAPA NIRMALA - Indonesia
|
GKL2231549009A1 | KAPLET SALUT SELAPUT; 245,1 MG | CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT 200
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI0665600217A1 | TABLET SALUT SELAPUT; 200 MG | CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT 200
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI0665600217A1 | TABLET SALUT SELAPUT | CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT MS FINE GRANULES 10%
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI1963200622B1 |
GRANULA;
0,5 G |
CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT MS FINE GRANULES 10%
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI1963200622B1 |
GRANULA;
0,5 G |
CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT MS FINE GRANULES 10%
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI1963200622B1 |
GRANULA;
0,5 G |
CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT MS FINE GRANULES 10%
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI1963200622B1 |
GRANULA;
0,5 G |
CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT MS FINE GRANULES 10%
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI1963200622A1 |
GRANULA;
0,3 G |
CEFDITOREN PIVOXIL | Berlaku |
|
MEIACT MS FINE GRANULES 10%
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - Indonesia
|
DKI1963200622A1 |
GRANULA;
0,3 G |
CEFDITOREN PIVOXIL | Berlaku |
|
TAFOXIL
PRATAPA NIRMALA - Indonesia
|
DKL2231549109A1 | KAPLET SALUT SELAPUT; 245,1 MG | CEFDITOREN PIVOXIL | Berlaku |
|
TAFOXIL
PRATAPA NIRMALA - Indonesia
|
DKL2231549109A1 | KAPLET SALUT SELAPUT | CEFDITOREN PIVOXIL | Berlaku |
← Sebelumnya
Hal 1 / 1
Berikutnya →